Data / Form D filings / InCellDx, Inc.
InCellDx, Inc.: Form D filings
InCellDx, Inc., a biotechnology company in Hayward, CA, filed 3 Form D notices with the SEC between 2010 and 2024. The latest, on July 23, 2024, reports $500,000 sold of a $13.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 30920 Huntwood Avenue, Hayward, CA, 94544
- Phone
- (650) 777-7630
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1494461
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 23, 2024 | New notice | $13,500,000 | $500,000 | $13,000,000 | 1 | Jul 16, 2024 | sec.gov |
| May 14, 2012 | New notice | $7,113,748 | $5,999,998 | $1,113,750 | 1 | Apr 27, 2012 | sec.gov |
| Jun 17, 2010 | New notice | $3,000,000 | $3,000,000 | 2 | Jun 4, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brian Recroft Brothen | Executive Officer | |
| Bruce Patterson | Executive Officer | |
| Chris Lawrence Wheeler | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 22, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what InCellDx, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.